GTC PHARMACEUTICALS
DEAD

Serial Number

78117254

Owner

GTC Biotherapeutics, Inc.

Attorney

Debra S. Serota

Filing Date

Mar 25, 2002

Add to watchlist:

No watchlists yet
View on USPTO

GTC PHARMACEUTICALS Trademark

Serial Number: 78117254

GTC PHARMACEUTICALS is a trademark filed by GTC Biotherapeutics, Inc. on March 25, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). The application is currently no longer active.

Owner Contact Info

GTC Biotherapeutics, Inc. (7 trademarks)

175 Crossing Boulevard
Framingham, MA 017019322

Entity Type: 03

Genzyme Transgenics Corporation (5 trademarks)

175 Crossing Boulevard
Framingham, MA 01701

Entity Type: 03

Trademark Details

Filing Date

March 25, 2002

Registration Date

Not Registered

Published for Opposition

October 28, 2003

Goods & Services

Processing and purifying of antithrombin III, recombinant human albumin, decorin, cystic fibrosis transmembrane conductance regulator, prolactin and urokinase obtained from the milk of transgenic animals, and cloned animals for use in medical and scientific research and for therapeutic and diagnostic use; custom manufacture of pharmaceuticals, biopharmaceuticals, proteins, cell culture and transgenic animal products

-- Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use as medical therapeutic reagents; transgenic and cloned animal products, namely, meat, tissue, cells or secretions for therapeutic and diagnostic use

-- Reagents for use in scientific or medical research; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use in the manufacture of pharmaceuticals and reagents; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms and for use in scientific or medical research; cells, cell lines and cell cultures for use in scientific and medical research; transgenic and cloned animal products, namely meat, tissue, cells or secretions for use in scientific or medical research

Isolation of pharmaceutical and nutritive and dietetic substances for medical purposes, medical testing services in the nature of medical engineering and genetic engineering of cloned and transgenic animals; animal breeding; transgenic and cloned animal breeding; animal husbandry, veterinary services; veterinary surgery; providing for the care and use of transgenic or cloned animals and products there from

Live laboratory animals and live transgenic animals

Providing technical advice, research, testing and analysis in the fields of biotechnology, molecular biology, chemistry, genetics, genetic engineering, pharmaceutical production, isolation of pharmaceutical and nutritive and dietetic substances, genealogy, chemicals, and pharmaceutical drug development; pharmaceutical drug development; medical research services in the nature of medical engineering services and genetic engineering services; isolation of pharmaceutical and nutritive and dietetic substances for research purposes

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 5, 2007 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 5, 2007 ABN6
SOU EXTENSION 3 GRANTED
Apr 13, 2006 EX3G
SOU EXTENSION 3 FILED
Apr 13, 2006 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 13, 2006 EEXT
SOU EXTENSION 2 GRANTED
Oct 20, 2005 EX2G
SOU EXTENSION 2 FILED
Oct 20, 2005 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 20, 2005 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 29, 2005 TCCA
SOU EXTENSION 1 GRANTED
Feb 23, 2005 EX1G
SOU EXTENSION 1 FILED
Feb 7, 2005 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 7, 2005 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 2, 2004 NOAM
CASE FILE IN TICRS
Sep 2, 2004 CFIT
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 18, 2004 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 15, 2003 ETOF
PUBLISHED FOR OPPOSITION
Oct 28, 2003 PUBO
NOTICE OF PUBLICATION
Oct 8, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2003 CNSA
EXAMINERS AMENDMENT MAILED
Aug 29, 2003 CNEA
FINAL REFUSAL MAILED
Aug 25, 2003 CNFR
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 31, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2003 CRFA
PAPER RECEIVED
May 27, 2003 MAIL
NON-FINAL ACTION MAILED
Apr 14, 2003 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 4, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2003 CRFA
PAPER RECEIVED
Jan 15, 2003 MAIL
NON-FINAL ACTION MAILED
Jul 15, 2002 CNRT
ASSIGNED TO EXAMINER
Jul 12, 2002 DOCK